This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Sandoz Glimepiride (2014-01-24)
- Starting date:
- January 27, 2014
- Posting date:
- January 28, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-37751
Recalled products
A. Sandoz Glimepiride, 1 milligram (mg)
B. Sandoz Glimepiride, 2 mg
Reason
Recall initiated following the discovery of blisters of Sandoz Glimepiride 2 mg tablets, Lot DM5336, erroneously packaged in a box identified Sandoz Glimepiride 1 mg. Therefore, units of this lot could be found in 1 mg or 2 mg inventories.
Depth of distribution
Wholesalers and pharmacies in Canada
Affected products
A. Sandoz Glimepiride, 1 mg
DIN, NPN, DIN-HIM
DIN 02269589
Dosage form
Tablet
Strength
1 mg
Lot or serial number
DM5336
Companies
- Recalling Firm
-
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
- Marketing Authorization Holder
-
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
B. Sandoz Glimepiride, 2 mg
DIN, NPN, DIN-HIM
DIN 02269597
Dosage form
Tablet
Strength
2 mg
Lot or serial number
DM5336
Companies
- Recalling Firm
-
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
- Marketing Authorization Holder
-
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA